Tapewire

NYSE · USD

TOVX

Theriva Biologics, Inc.

Export transactions ↓
Tapewire entity
7919
SEC CIK
0000894158
Parsed reports
60

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 20, 2017 Filed Dec 21, 2017 22:20 UTC GrantStock Options · Derivative 200,000 $0.00 Strike: $0.52 $0.00
Disclosure

SEC source: 0001144204-17-064825 · tv481801_4.xml · derivative · entry 1

Wolf Jeffrey Alan · CIK 0001381450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2024-12-19

F1 · shares: These stock options vest in full on the one year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest in full on the one year anniversary of the grant date.

Read SEC document
December 20, 2017 Filed Dec 21, 2017 22:20 UTC GrantStock Options · Derivative 200,000 $0.00 Strike: $0.52 $0.00
Disclosure

SEC source: 0001144204-17-064828 · tv481802_4.xml · derivative · entry 1

Kraws Jeffrey J · CIK 0001380918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2024-12-19

F1 · shares: These stock options vest in full on the one year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest in full on the one year anniversary of the grant date.

Read SEC document
December 20, 2017 Filed Dec 21, 2017 22:18 UTC GrantStock Options · Derivative 200,000 $0.00 Strike: $0.52 $0.00
Disclosure

SEC source: 0001144204-17-064824 · tv481800_4.xml · derivative · entry 1

Tarriff Scott · CIK 0001469124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2024-12-19

F1 · shares: These stock options vest in full on the one year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest in full on the one year anniversary of the grant date.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 22:52 UTC Exercise / conversionStock Options (right to buy) · Derivative 228,773 $0.00 Strike: $0.09 $0.00
Disclosure

SEC source: 0001144204-17-015198 · v462045_4.xml · derivative · entry 2

Kraws Jeffrey J · CIK 0001380918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 228,773 shares

Expires 2017-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Reflects a 1-for-3 reverse stock split effected in 2007.

F1 · shares: Reflects a 1-for-3 reverse stock split effected in 2007.

F1 · derivative.exercise_date: Reflects a 1-for-3 reverse stock split effected in 2007.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 22:52 UTC Exercise / conversionCommon Stock 228,773 $0.09 $20,589.57
Disclosure

SEC source: 0001144204-17-015198 · v462045_4.xml · nonDerivative · entry 1

Kraws Jeffrey J · CIK 0001380918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 17, 2017 Filed Jan 18, 2017 22:08 UTC
Sliman Joseph A.Chief Medical Officer
GrantStock Options · Derivative 188,927 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001144204-17-002734 · v457073_4.xml · derivative · entry 1

Sliman Joseph A. · CIK 0001694213 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,927

Underlying: Common Stock · 188,927 shares

Expires 2024-01-16

F1 · shares: These options will vest monthly on a pro rata basis over 36 consecutive months.

F1 · derivative.exercise_date: These options will vest monthly on a pro rata basis over 36 consecutive months.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:02 UTC
SHALLCROSS STEVEN AChief Financial Officer
GrantStock Options · Derivative 500,000 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001144204-16-137735 · v454259_4.xml · derivative · entry 1

SHALLCROSS STEVEN A · CIK 0001263501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2023-11-29

F1 · shares: These options will vest monthly on a pro rata basis over 36 consecutive months.

F1 · derivative.exercise_date: These options will vest monthly on a pro rata basis over 36 consecutive months.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:07 UTC GrantStock Options · Derivative 168,750 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001144204-16-137744 · v454264_4.xml · derivative · entry 1

Tarriff Scott · CIK 0001469124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,750

Underlying: Common Stock · 168,750 shares

Expires 2023-11-29

F1 · shares: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:06 UTC
Riley Jeffrey ScottDirector · Chief Executive Officer
GrantStock Options · Derivative 1,129,000 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001144204-16-137742 · v454263_4.xml · derivative · entry 1

Riley Jeffrey Scott · CIK 0001487645 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,129,000

Underlying: Common Stock · 1,129,000 shares

Expires 2023-11-29

F1 · shares: These options will vest monthly on a pro rata basis over 36 consecutive months.

F1 · derivative.exercise_date: These options will vest monthly on a pro rata basis over 36 consecutive months.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:05 UTC GrantStock Options · Derivative 168,750 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001144204-16-137741 · v454262_4.xml · derivative · entry 1

Wolf Jeffrey Alan · CIK 0001381450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,750

Underlying: Common Stock · 168,750 shares

Expires 2023-11-29

F1 · shares: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:03 UTC GrantStock Options · Derivative 168,750 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001144204-16-137739 · v454260_4.xml · derivative · entry 1

Kraws Jeffrey J · CIK 0001380918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,750

Underlying: Common Stock · 168,750 shares

Expires 2023-11-29

F1 · shares: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

F1 · derivative.exercise_date: These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date.

Read SEC document
November 18, 2016 Filed Nov 18, 2016 16:12 UTC GrantSeries B Warrant · Derivative 300,000 Not disclosed Strike: $1.72 Not disclosed
Disclosure

SEC source: 0001144204-16-135295 · v453318_4.xml · derivative · entry 3

Tarriff Scott · CIK 0001469124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2017-12-31

F1 · price: The shares of common stock were sold together with the Series A Warrant and the Series B Warrant. The purchase price for each share of common stock and accompanying warrant was $1.00.

F1 · derivative.exercise_date: The shares of common stock were sold together with the Series A Warrant and the Series B Warrant. The purchase price for each share of common stock and accompanying warrant was $1.00.

Read SEC document
November 18, 2016 Filed Nov 18, 2016 16:12 UTC GrantSeries A Warrant · Derivative 300,000 Not disclosed Strike: $1.43 Not disclosed
Disclosure

SEC source: 0001144204-16-135295 · v453318_4.xml · derivative · entry 2

Tarriff Scott · CIK 0001469124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2020-11-18

F1 · price: The shares of common stock were sold together with the Series A Warrant and the Series B Warrant. The purchase price for each share of common stock and accompanying warrant was $1.00.

F1 · derivative.exercise_date: The shares of common stock were sold together with the Series A Warrant and the Series B Warrant. The purchase price for each share of common stock and accompanying warrant was $1.00.

Read SEC document
November 18, 2016 Filed Nov 18, 2016 16:12 UTC GrantCommon Stock 300,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001144204-16-135295 · v453318_4.xml · nonDerivative · entry 1

Tarriff Scott · CIK 0001469124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

F1 · price: The shares of common stock were sold together with the Series A Warrant and the Series B Warrant. The purchase price for each share of common stock and accompanying warrant was $1.00.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.